MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan
· Delayed Price · Currency is TWD 6.57
-0.26 (-3.81%)
Apr 29, 2026, 2:00 PM CST
MARX Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 22.46 | 74.67 | 152.83 | 27.73 | 0.18 |
| Short-Term Investments | 5 | 3.5 | - | - | - |
| Cash & Short-Term Investments | 27.46 | 78.17 | 152.83 | 27.73 | 0.18 |
| Cash Growth | -71.97% | -48.85% | 451.08% | 15479.78% | - |
| Accounts Receivable | 89.79 | 120.02 | 98.42 | 54.95 | - |
| Other Receivables | 8.41 | 3.92 | 4.62 | - | - |
| Receivables | 98.19 | 123.94 | 103.04 | 54.95 | - |
| Inventory | 249.39 | 164.31 | 70 | 12 | - |
| Prepaid Expenses | 14.19 | 35.93 | 13.98 | 0.83 | - |
| Other Current Assets | 7.12 | 4.95 | 3.19 | 0.56 | - |
| Total Current Assets | 396.35 | 407.3 | 343.04 | 96.07 | 0.18 |
| Property, Plant & Equipment | 221.99 | 217.19 | 4.26 | 4.73 | - |
| Long-Term Investments | - | - | - | - | 13.5 |
| Goodwill | 26.25 | 26.25 | 5.37 | - | - |
| Other Intangible Assets | 71.38 | 65.36 | 30.1 | - | - |
| Long-Term Deferred Tax Assets | 8.29 | 6.56 | 4.92 | 1.94 | 0.09 |
| Other Long-Term Assets | 8.76 | 8.54 | 7.15 | 0.45 | 0.03 |
| Total Assets | 733.01 | 731.2 | 394.85 | 103.19 | 13.8 |
| Accounts Payable | 55.18 | 88.88 | 23.72 | 5.26 | - |
| Accrued Expenses | 40.3 | 58.25 | 39.77 | 12.98 | 0.5 |
| Short-Term Debt | 176 | 98 | - | 10 | - |
| Current Portion of Long-Term Debt | 16.64 | 5.27 | - | - | - |
| Current Portion of Leases | 4.85 | 3.9 | 1.26 | 2.97 | - |
| Current Income Taxes Payable | - | - | - | 3.41 | - |
| Current Unearned Revenue | 39.12 | 40.26 | 25.08 | 2.28 | - |
| Other Current Liabilities | 10.28 | 13.87 | 11.2 | 4.6 | 0.16 |
| Total Current Liabilities | 342.36 | 308.43 | 101.04 | 41.5 | 0.66 |
| Long-Term Debt | 171.69 | 165.04 | - | - | - |
| Long-Term Leases | 3.83 | 5.11 | 0.62 | 0.87 | - |
| Long-Term Deferred Tax Liabilities | 1.33 | 1.38 | 0.2 | 0.08 | - |
| Total Liabilities | 519.21 | 479.95 | 101.86 | 42.45 | 0.66 |
| Common Stock | 126.5 | 126.5 | 124.51 | 40.8 | 8.05 |
| Additional Paid-In Capital | 124.23 | 220.48 | 186.03 | 17.98 | 3.21 |
| Retained Earnings | -36.92 | -95.73 | -17.55 | 1.95 | 1.89 |
| Shareholders' Equity | 213.8 | 251.25 | 292.99 | 60.73 | 13.14 |
| Total Liabilities & Equity | 733.01 | 731.2 | 394.85 | 103.19 | 13.8 |
| Total Debt | 373 | 277.32 | 1.88 | 13.84 | - |
| Net Cash (Debt) | -345.55 | -199.15 | 150.94 | 13.89 | 0.18 |
| Net Cash Growth | - | - | 986.39% | 7705.62% | - |
| Net Cash Per Share | -0.69 | -0.40 | 0.47 | 0.04 | 0.01 |
| Filing Date Shares Outstanding | 505.98 | 505.98 | 498.06 | 163.21 | 32.18 |
| Total Common Shares Outstanding | 505.98 | 505.98 | 498.06 | 163.21 | 32.18 |
| Working Capital | 53.98 | 98.87 | 242.01 | 54.57 | -0.48 |
| Book Value Per Share | 0.42 | 0.50 | 0.59 | 0.37 | 0.41 |
| Tangible Book Value | 116.17 | 159.64 | 257.52 | 60.73 | 13.14 |
| Tangible Book Value Per Share | 0.23 | 0.32 | 0.52 | 0.37 | 0.41 |
| Land | 129.46 | 129.46 | - | - | - |
| Buildings | 69.13 | 69.13 | - | - | - |
| Machinery | 11.74 | 9.13 | 2.7 | 1.03 | - |
| Construction In Progress | - | - | 0 | 0.02 | - |
| Leasehold Improvements | 8.1 | 3.75 | 1.1 | 0.44 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.